Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Phase II Trial of Cediranib (AZD2171) Versus Placebo in Addition to Cisplatin/Gemcitabine Chemotherapy for Patients With Advanced Biliary Tract Cancers

NCT00939848 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT00939848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00939848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Phase II Trial of Cediranib (AZD2171) Versus Placebo in Addition to Cisplatin/Gemcitabine Chemotherapy for Patients With Advanced Biliary Tract Cancers
Lead sponsor
University College, London
Phase
Phase 2/3
Overall status
Completed
Start date
April 30, 2011
Completion date
September 30, 2014
Enrollment
124 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract neoplasms